HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Hong Kong
62023081975.2
Filed on 2023-11-01
62023081975.2
Filed on 2023-11-01
CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS
US Application 18/359,071
Filed on 2023-07-26
Filed on 2023-07-26
Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains
Hong Kong
42023078902.6
Filed on 2018-06-28
42023078902.6
Filed on 2018-06-28
CELL-BARCODE RECORDER DEVICES AND METHODS
Patent Cooperation Treaty
PCT/US2023/069782
Filed on 2023-07-07
PCT/US2023/069782
Filed on 2023-07-07
Human Monoclonal Antibody Against Human Folate Receptor Beta
European Patent
18161859.6
Filed on 2011-09-09
18161859.6
Filed on 2011-09-09
NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY
Japan
2023-090523
Filed on 2023-05-31
2023-090523
Filed on 2023-05-31
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-MESOTHELIN IMMUNOTHERAPY
Japan
2022-014136
Filed on 2022-02-01
2022-014136
Filed on 2022-02-01
IMMUNOGENS AND METHODS FOR INDUCING AN IMMUNE RESPONSE
Patent Cooperation Treaty
PCT/US2023/069057
Filed on 2023-06-26
PCT/US2023/069057
Filed on 2023-06-26
IMIDAZO[1,2-A]PYRAZINE AND IMIDAZO[1,2-A]PYRIDINE BASED TYROSYL-DNA
PHOSPHODIESTERASE I (TDP1) INHIBITORS
European Patent
22705222.2
Filed on 2023-08-08
22705222.2
Filed on 2023-08-08